Does the method fit the task, and was the run checked?
When a peptide quotation says “HPLC tested”, ask what that statement covers. A method-validation report concerns the analytical procedure and its intended purpose. A system-suitability record concerns checks used with that procedure. A COA reports results for the identified sample or batch. These records should connect, without being treated as interchangeable.
ICH Q2(R2) explains validation in terms of showing that a procedure suits its intended purpose. It also describes system suitability as a regular performance check developed with the procedure. Read the corrected ICH Q2(R2), introduction and section 2 (PDF). This pharmaceutical guidance provides reference principles for document questions; it does not establish approval, certification or compliance for our catalogue.
Our chromatogram guide covers reading and comparing the plot. This page asks a separate purchasing question: which records support the procedure behind that plot and the checks for its run?
Start with the exact analytical purpose.
Write the requested measurement against the order line. Are you asking about identity, chromatographic area purity, measured content or a defined impurity? Ask which purpose the named method was assessed for. A broad statement that a laboratory has a validated HPLC method leaves that scope unclear.
For BPC-157 or KPV, request the exact material and method reference. For GHK-Cu, make the reported material and content basis explicit. For GLOW or KLOW, ask which stated components the assessment covers; unresolved identities, component amounts and totals remain open questions.
Record whether the examined sample represents bulk material, a vial or another defined presentation. An analytical record should not be expanded into proof about every kit component. Use the purity versus content guide when the requested measurement itself needs clarification.
Ask what was assessed and what the reviewer concluded.
Request the procedure identifier, revision, intended purpose, material or sample scope, assessment reference and dated conclusion. Ask which performance characteristics were considered relevant and where the supporting summary can be reviewed. A document headed “validation” still needs a traceable method and scope.
| Review field | Practical document question |
|---|---|
| Specificity or selectivity | What evidence addresses interference relevant to this measurement? |
| Accuracy | What comparison or assessment supports the reported result? |
| Precision | Which sources of variation were assessed for the intended use? |
| Range and response | Which stated range and reporting basis does the conclusion cover? |
| Low-level reporting | If relevant, what supports the laboratory’s detection or quantitation claims? |
ICH Q2(R2), section 3, discusses performance characteristics according to analytical purpose. The table is a request for clarification, not a universal test list or acceptance threshold. Your technical reviewer decides what evidence is relevant to the proposed measurement.
Keep the suitability record with the reported analysis.
Ask for the run or sequence reference, applicable method revision, identified checks, acceptance criteria, observed results and recorded review status. Reconcile those references with the sample report. A general statement that equipment was serviced does not identify the analytical checks for the reported run.
FDA’s ICH Q14 guidance places system suitability within the analytical procedure’s control strategy. See section 6 of Q14 (PDF). Its robustness discussion addresses how procedure performance is assessed when relevant parameters vary. Those concepts help distinguish development evidence from routine checks; they do not supply a ready-made limit for every peptide.
USP’s public Chromatography chapter overview also identifies system suitability within its chromatography framework. If a report cites a compendial chapter, ask the issuer to identify the applicable edition, procedure and scope. A chapter reference alone is not a certificate for the supplied material.
Keep missing answers visible before order acceptance.
| Record | Reference to retain | Open question |
|---|---|---|
| Requested measurement | Material, purpose and reporting basis | Does it match the purchase requirement? |
| Method assessment | Procedure revision and validation-summary reference | What scope and conclusion are supported? |
| Run checks | Run ID, check results and review status | Do they connect to this analysis? |
| Sample result | Report version, sample and proposed lot | Is the commercial link clear? |
Mark each answer received, awaiting clarification or requiring technical review. Keep the issuer’s explanation beside the original document. Purchasing should not invent missing criteria, edit a laboratory result or infer a pass from a cropped screenshot.
For the wider batch-document review, continue with the COA checklist and reference-standard guide.
A familiar peptide name does not settle a revised procedure.
If a later offer uses a different method, revision or laboratory, ask what changed and which assessment supports the new scope. Retain both references and the reviewer’s decision. Do not assume that an earlier validation summary automatically covers a revised method or a different blend.
For repeat supply, connect this review to the accepted specification in your reorder record. Material, packaging and analytical changes can need different reviewers. A new branded carton does not, by itself, explain an analytical-method change.
Send the measurement question with the order brief.
Email the named peptides, requested quantities, vial or defined pen-style kit presentation and destination in the USA, Canada or Australia. Include the intended measurement and documents your reviewer needs. All Wholesale amounts, pack contents, available records and any separately agreed analytical scope are confirmed during enquiry.
Wholesale Lab Peptides has warehouses in the USA, Canada, Australia and Hong Kong. Confirm current local availability and dispatch for the selected order. Browse the catalogue, discuss OEM and private-label supply, or use our contact page.
Discuss analytical documentationEmail sales@wholesalelabpeptides.com with the relevant method and report references.